Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma

To identify risk factors for infection in patients with diffuse large B cell lymphoma (DLBCL) undergoing rituximab, cyclophosphamide, vincristine, adriamycin and prednisolone (R-CHOP) treatment. All patients with DLBCL who received R-CHOP from 2004–2014 in a tertiary Australian hospital were identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Dendle, Claire, Gilbertson, Michael, Spelman, Tim, Stuart, Rhonda L., Korman, Tony M., Thursky, Karin, Opat, Stephen, McQuilten, Zoe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493675/
https://www.ncbi.nlm.nih.gov/pubmed/28667319
http://dx.doi.org/10.1038/s41598-017-04495-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493675/
https://www.ncbi.nlm.nih.gov/pubmed/28667319
http://dx.doi.org/10.1038/s41598-017-04495-x

Ejemplares similares